Objective: The incidence of lung cancer is four times higher in people with chronic obstructive pulmonary disease (COPD) compared with the general population.
The similarity in symptoms is of particular concern because people with COPD are four times more likely to develop lung cancer than the general population. 6 One of the problems might be that people with COPD do not know that COPD poses an increased risk of lung cancer, which is independent from the risk posed by smoking, or that health professionals do not know it or consider it salient in consultations. 7, 8 People with COPD will experience ongoing lung symptoms, and attributing any changes in symptoms or new symptoms to a cause other than their existing diagnosis of COPD may be challenging. In a previous study, a history of COPD was one of the few factors independently associated with increased time before seeking initial contact with a health care professional, 9 and qualitative research with people experiencing symptoms suggestive of lung cancer confirmed that symptom appraisal was made difficult by lung comorbidities masking new respiratory changes. [10] [11] [12] The common sense model 13 describes the self-regulation of health and illness with the goal being able to manage or regulate the perceived threat. More recently, an integrated symptom-response framework (ISRF) 14 has been proposed ( Figure S1 ) that provides a cross-disciplinary model of symptom appraisal, where responses to symptoms are considered an iterative process influenced by the self, social interaction, cultural expectations, and social structure. Emphasis is on the changeable and cyclical nature of symptom appraisal, which is particularly important for COPD, where changes in existing respiratory symptoms may be a critical cue to action.
The impact of comorbidities on cancer diagnosis more generally has received little attention, and there is a lack of theoretical underpinning to inform our understanding. 15 Furthermore, previous work considering responses to potential symptoms of lung cancer has examined symptom appraisal post cancer diagnosis 11 or post referral 12 but has not attempted to capture the symptom appraisal and helpseeking process in an everyday context of people living with COPD.
We used the ISRF to explore how people with COPD appraise and respond to potential lung cancer symptoms.
2 | METHODS
| Design
We conducted a qualitative study involving semistructured interviews with men and women with COPD in Glasgow, Scotland, UK, between
July 2016 and May 2017 (Data S1).
| Participants and procedure
Glasgow provided an ideal setting for the study because rates of lung cancer in Scotland are among the highest in the world. We recruited people diagnosed with COPD aged 40 years or older using a specialist We finished interviewing participants when we reached data saturation, using a stopping criterion of three interviews after new ideas stopped emerging. 16 In total, 17 men and 23 women were interviewed, ranging in age from 40 to 87 years (Table S1 ).
| Topic guide
We developed a topic guide to explore interviewees' experience of lung symptoms over the previous 6 to 12 months (Data S2). 
| RESULTS
Participants were interviewed in their own homes, apart from two who requested to be interviewed in cafes. Interviews lasted an average of 42 minutes (range: 24-72 min). The analysis was organised into four main "circles of influence" on the response to symptoms (self, social interaction, culture, and social structure; Figure 1 ). Each influence is described with supporting quotes from participants, along with their participant number, gender, and age.
| Influence-self
Knowledge of COPD and their own body were prominent in participants' accounts. Participants described having always had "chest problems"; eg, they had suffered from asthma since childhood and then later developed COPD. Participants emphasised that their long history of COPD meant that they had come to know their own bodies and felt they had the expertise and confidence to advise their doctors on appropriate treatment. One participant described how she had educated herself about her condition. Participants said that because they knew their body so well, they were able to make sound judgements about help seeking.
Actually, but I think your body's the best doctor, you Participants also provided examples of other people noticing symptoms before they did.
They would notice the wheeziness when I am sitting down. Short of breath when I am sitting down as well.
That's what they would notice and they would notice the wheeziness and just probably the way I look, kind of grey. [P32, female, age 53]
Participants talked about family members encouraging them to seek help for a changing or worsening symptom. Participants described how family members would even go so far as to arrange appointments or drive them to the hospital:
They 3.4 | Influence-social structure While difficulties in accessing care were talked about among our participants, they also described that they had better access to health services because of their COPD diagnosis. Doctors acknowledged the seriousness of their symptoms and accommodated them with emergency appointments or prescriptions.
I have got what they call "save" antibiotics in the house. Participants in the current study did not identify any potential link between their symptoms and lung cancer, nor recognise that they were at higher risk, even after specific probing by the interviewer. This is consistent with previous research, which reported that public awareness of COPD as a lung cancer risk factor, independent of cigarette smoking, is low. 8 Moving beyond social interaction to wider cultural influences, we identified a concern among COPD participants about being labelled a "time-waster" and valued cultural attributes of stoicism.
Worry about wasting the doctor's time is a well-recognised barrier to prompt help seeking 11, 22, 23 and demonstrates the complex and delicate moral balance patients have to make between responsible use of health care services and not taking unnecessary risks with their health.
Despite having a recognised chronic condition requiring medical involvement, participants were keen to distance themselves from those considered time-wasters and instead stressed that they would consult their doctor only when absolutely necessary. Stoicism and acceptance of poor health also manifested as fatalism, with one man (aged 55 years) saying wearily "I've lived my life." Fatalism has previously been identified as a barrier to medical help seeking, 24 and this is important because raising awareness of a link between COPD and cancer may be detrimental if it leads to increased fatalism. Raising awareness of the link between COPD and lung cancer should therefore be conducted alongside raising awareness of the benefits of early diagnosis.
According to the ISRF, 14 social structure can influence responses to symptoms directly (eg, through health care access) or indirectly (though social networks' access to resources, knowledge, and so on).
We observed evidence for both. Firstly, there was a juxtaposition between commonly identified access barriers to help seeking, alongside expedited access due to having COPD. Different dimensions of accessing health care were highlighted, including lack of availability and problems with accessibility. 25 Conversely, participants described expedited access or "short-cuts" to accessing medical care because of their condition. Although this may appear helpful on one level, it may also result in health care professionals attributing new or changing symptoms to existing medical conditions rather than considering alternative explanations.
Social isolation also impacted on help seeking-COPD participants described lack of mobility and the need to hide embarrassing or worsening symptoms. Evidence of social isolation in COPD patients has been identified before, 26 but our study highlights that this may have wider consequences on consulting behaviour.
A major strength of this study is that it is the first to examine the process of symptom appraisal of potential warning signs for cancer in patients with an existing health condition prior to the potentially biasing effects of cancer diagnosis or referral on suspicion of cancer. The study adopted a theoretically driven approach to capture the symptom appraisal process in an everyday context for a diverse sample of men and women of relatively low socioeconomic status.
| Study limitations
Glasgow was purposively identified as a good site for the study because of high prevalence of COPD and lung cancer; however, we acknowledge that our sample is geographically limited. We used a specialist qualitative research company for recruitment that may have biased our sample because these people are interested in taking part in research. However, on the basis of informal feedback from participants, it is our belief that this form of recruitment allowed us to reach participants who would not have engaged with more conventional approaches.
| Clinical implications
Our study provides insights into how to intervene at different levels of influence to improve the likelihood of patients and health care professionals suspecting and acting on potential lung cancer. Studies testing health care-based interventions addressing symptom awareness/normalisation and fatalism in patients at high risk of lung cancer are ongoing. 27, 28 Our study highlights the potential need for similar interventions in patients with COPD, and we have developed 
BOX 1 Recommendations
Finding Recommendations
Cancer was not considered a potential explanation for chest symptoms.
•Alert people with COPD to risk of lung cancer.
•Alert people with COPD to consult with changes in symptoms.
•Encourage relevant charities/ support groups to include information about lung cancer risk in communications.
Family or friends noticed changes in symptoms and encourage help seeking.
•Provide information aimed at empowering patients and family members to speak about symptoms and take action.
•Encourage family members to attend consultations.
People felt isolated by their COPD.
•Encourage patient engagement with COPD services such as pulmonary rehabilitation programmes or other well-being/exercise classes to gain social support from others with COPD.
Participants visited health professionals frequently, but lung cancer risk was not discussed.
•Alert health professionals to be vigilant to lung cancer risk in COPD patients.
•Move away from a "disease silo" approach. Consultations could include the question from the health professional, "is there anything else?" This recommendation is transferable to other patient groups with pre-existing conditions at risk of developing cancer.
COPD, chronic obstructive pulmonary disease.
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